Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

5-Bromoimidazole Pyrazine

    • Product Name 5-Bromoimidazole Pyrazine
    • Alias 5-Bromo-1H-imidazo[4,5-b]pyrazine
    • Einecs 934-679-0
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    555820

    Productname 5-Bromoimidazole Pyrazine
    Molecularformula C5H3BrN4
    Molecularweight 199.01 g/mol
    Casnumber 552317-54-5
    Appearance Off-white to light brown solid
    Purity Typically ≥ 97%
    Solubility Slightly soluble in water; soluble in DMSO and DMF
    Smiles Brc1ncc2ncncc2n1
    Inchikey JGHUPZKZWCBMMQ-UHFFFAOYSA-N
    Storagecondition Store at 2-8°C, protect from light and moisture

    As an accredited 5-Bromoimidazole Pyrazine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 5-Bromoimidazole Pyrazine

    Applications of 5-Bromoimidazole Pyrazine in Industrial Manufacturing

    5-Bromoimidazole Pyrazine serves as a highly specialized intermediate in advanced chemical syntheses. Our manufacturing facilities supply this molecule to sectors that demand consistency in purity, traceability, and high-yield transformation within strictly regulated downstream environments. Below we detail primary application areas, each with distinct process requirements and industry compliance factors.

    1. Pharmaceutical Intermediate for Antineoplastic Agents

    Leading oncology formulation laboratories utilize 5-Bromoimidazole Pyrazine in multi-step syntheses of novel pyridine-based antineoplastics. The compound functions as a heterocyclic building block that undergoes nucleophilic substitution and cyclization within controlled GMP suites. End-users require validated analytical methods and complete documentation batch-to-batch. All source materials must conform to international pharmacopoeial monographs and trace impurity limits tailored to injectable APIs.

    Industry compliance standards

    • ICH Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
    • USP-NF and EP monograph traceability for starting materials
    • US FDA 21 CFR Part 211 for finished pharmaceutical products
    • EU GMP Part II – Basic Requirements for Active Substances used as Starting Materials

    Typical usage ratio

    • Utilization at 6–12% w/w in reference to overall API precursor batch
    • Adjusted according to nucleophilic partner and cycle scale (mg to kg)

    Downstream process integration

    • Charged at the step of heterocycle ring assembly post-initial nitration
    • Subjected to controlled temperature and pH during halogen exchange
    • Monitored through in-process HPLC for complete conversion

    Final product types

    • Small-molecule antineoplastic drugs (oncology APIs)
    • Experimental clinical trial formulations
    • Reference standards for QC labs
    • Pyrimidine-pyrazine hybrids in pipeline development

    2. Agrochemical Synthesis: Insecticide Precursor

    Major crop protection companies employ this pyrazine derivative when producing new-generation systemic insecticides. The compound enters the process at the heterocycle coupling stage, typically under anhydrous and inert conditions. Custom protocols require tight control on residual solvents and byproducts to conform with pesticide formulation standards. Documentation tracks full batch genealogy back to sourced raw materials. Comprehensive waste and environmental audits accompany each campaign under certified QHSE management systems.

    Industry compliance standards

    • FAO/WHO Specifications for Plant Protection Products
    • OECD Test Guidelines: Chemical Substances Used in Agriculture
    • ISO 9001:2015 Quality Management for Agrochemicals
    • REACH Registration, Evaluation, Authorisation and Restriction of Chemicals (Europe)

    Typical usage ratio

    • 5–10% by moles relative to overall synthetic substrate load
    • Adjusted based on target molecule scaffold and desired EC50 level in final formulation

    Downstream process integration

    • Chemical entered at nucleophilic heterocycle base addition prior to final formulation blending
    • Filtration, solvent exchange, and vacuum recrystallization post-coupling
    • Purity controlled by GC-MS and specific residue analyses (chlorinated byproducts)

    Final product types

    • Active insecticide technical concentrates
    • Finished crop protection formulations (EC, WP, SC)
    • Seed coating agents
    • Export-grade pesticide intermediates

    3. API Synthesis for Antiviral Compounds

    Research API facilities and licensed manufacturers incorporate this raw material in multi-step antiviral agent syntheses. Controlled addition of the 5-bromo functional group enables formation of specific bioactive heterocyclic scaffolds, essential for medicinal chemistry programs seeking novel mode of action compounds. All handling adheres to validated cleaning and cross-contamination protocols. Incoming lots undergo FTIR and NMR verification prior to any process exposure, in line with DMF (Drug Master File) submissions.

    Industry compliance standards

    • ICH Q11 Development and Manufacture of Drug Substances
    • FDA DMF (Type II) filing requirements
    • Ph. Eur. 5.1.10 for control of impurities in synthetic starting materials
    • ISO 14644-1 Cleanroom Standards for pharmaceutical manufacture

    Typical usage ratio

    • Ranges from 2% up to 8% relative to all-step intermediates
    • Optimized based on anticipated yield/purity requirements and downstream conversion rate

    Downstream process integration

    • Direct charge at the heterocyclic substitution stage
    • Batchwise and continuous flow allowed depending on facility setup
    • Post-reaction workup includes liquid-liquid extraction and ion-exchange refinement

    Final product types

    • Nucleoside/nucleotide-class antiviral intermediates
    • Research-grade drug substances for non-clinical studies
    • Phase II/III clinical batch APIs
    • Reference markers for LC/MS assay development

    4. Advanced Material Chemistry: OLED and Sensing Films

    Specialty electronics material producers demand high-purity heterocyclic halides for OLED precursor manufacture and sensor film development. 5-Bromoimidazole Pyrazine supplies electronic grade pyrazine units for monomer synthesis, applied within high-vacuum evaporation or solution-processing techniques. Packaging, storage, and process integration occur under nitrogen to avoid trace water and oxide interference. Batch records retain full analytical profiles and source traceability to meet stringent device reliability QMS requirements.

    Industry compliance standards

    • ISO 9001:2015 Quality Management for advanced materials
    • RoHS Directive 2011/65/EU for restricted substances in electronics
    • IPC-5701 Cleanliness Standards for Unpopulated Boards
    • Customer-mandated impurity and particle counters for electronics interfaces

    Typical usage ratio

    • 1–3% molar ratio in relation to co-monomer or functionalized unit batch size
    • Precisely modulated based on luminescence or conductivity requirements in the target film or device

    Downstream process integration

    • Introduced at the click-chemistry or Suzuki coupling stage in monomer or oligomer assembly
    • Gas-phase or solvent-assisted deposition depending on device type (OLED, display, sensor)
    • Post-processing includes ultra-filtration and particle count validation

    Final product types

    • OLED substrates and precursor monomers
    • Printed sensing films and photoresist layers
    • Electro-optical device prototypes
    • Advanced flexible display modules
    Free Quote

    Competitive 5-Bromoimidazole Pyrazine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Exploring 5-Bromoimidazole Pyrazine: A Fresh Perspective on a Versatile Compound

    A Closer Look at 5-Bromoimidazole Pyrazine

    Anyone who has spent time working in a chemistry lab or keeping up with pharmaceutical research knows there’s a constant demand for reliable, high-purity compounds. One such compound, 5-Bromoimidazole Pyrazine, draws particular attention for its multi-purpose nature and well-characterized chemical behavior. Compared to more established reagents in the imidazole family, this compound places special emphasis on application-driven features and user trust, answering the evolving technical needs of modern science.

    Understanding Its Structure and Specifications

    The molecular composition of 5-Bromoimidazole Pyrazine contains both a bromo group and pyrazine ring, fusing two powerful moieties in a single molecule. Chemists quickly notice its defined molecular weight, rational chemical backbone, and strong aromatic character. Through HPLC analysis and NMR, the high purity levels stand out—crucial for reproducibility in both laboratory synthesis and scale-up scenarios. Impurity profiles remain tight, which builds lab confidence when 5-Bromoimidazole Pyrazine enters a new project or process stream.

    Key Uses: Research, Development, and Beyond

    Laboratory researchers and industrial chemists often look for compounds that can handle a diverse set of reactions. 5-Bromoimidazole Pyrazine supports med-chem exploration, helping push new synthetic routes and unique molecule designs, especially for small molecule discovery. The bromo substituent, in particular, opens doors for selective halogenations, cross-couplings, and other targeted transformations, giving the compound great flexibility in maneuvering through complex synthetic challenges.

    It’s easy to be skeptical when new compounds make promises about versatility, but in practice, colleagues have told stories about shaving days off reaction timelines and lowering waste using this very reagent. Organic synthesis projects in universities and drug discovery settings benefit from the compound’s predictable behavior, both with standard protocols and exploratory work in green chemistry. Feedback points to reliable performance during Suzuki and Buchwald-Hartwig reactions as a clear differentiator, which matters when research budgets and deadlines are tight.

    Stability and Handling: Day-to-Day Reliability

    Working with specialty chemicals, I’ve seen the trouble caused by unstable or moisture-sensitive reagents. 5-Bromoimidazole Pyrazine sticks out for being manageable in everyday bench conditions. Packaging addresses common storage and transfer complaints, giving busy labs one less thing to worry about when running multiple reactions. Few things undermine credibility faster than lost yield due to decomposition or unscheduled reordering—reliable shelf-life gives this product extra credibility for seasoned chemists who don’t have time to waste on unstable intermediates.

    Comparison With Other Imidazoles and Pyrazine Derivatives

    Many professionals will ask how 5-Bromoimidazole Pyrazine diverges from other halogenated imidazoles or simple pyrazine analogs. In other words: why not use the old standbys? Traditional bromoimidazoles or mono-halogenated pyrazines may lack the fine-tuned reactivity balance this compound achieves. The fusion of the imidazole and pyrazine cores shifts the electron distribution, facilitating more responsive reactivity to standard conditions. This subtle tweak in reactivity can lead to better selectivity or reduced byproduct formation during challenging reactions—factors that drive up project costs or clog downstream purification.

    Some colleagues have mentioned that while working with other halo-derivatives, they found downstream modifications and functionalisations less predictable. Replacing older reagents with 5-Bromoimidazole Pyrazine cut down on time spent troubleshooting, which impacts both morale and project throughput.

    Trust in Quality and Sourcing

    Authenticity and reliability jump to the front of my mind when new products hit the lab. Sourcing trustworthy chemicals, especially under increasing regulatory scrutiny, isn’t just about ticking boxes on a safety protocol. Repeated hands-on results from batch to batch establish a reputation. When labs pick up 5-Bromoimidazole Pyrazine, they look for consistency in melting point, purity measures like HPLC and NMR, and batch quality confirmed by COA (Certificate of Analysis)—all these criteria give the user control and confidence.

    I remember discussing supply chain headaches with colleagues during periods of global supply instability. A product that arrives according to promised timelines, matches specs, and doesn’t need costly relabeling or requalification helps keep projects on track. As one chemist in an industrial lab said: “If it works the same every time, that gives us the breathing room to innovate further up the process.”

    Reliability in Reaction Scalability

    Some compounds work well in small-scale flask reactions, yet fail to deliver when scaled up to multi-liter processes. 5-Bromoimidazole Pyrazine stands apart for its reproducible behavior from milligram samples in discovery labs to kilogram quantities in pilot plants. Scale-up teams can transition from academic literature or early-stage development to bulk production without hit-or-miss surprises. This benefit reflects the experience of teams who have shepherded research hits into pharmaceutical leads or material innovations, only to watch inconsistent raw materials cost weeks or months of progress.

    Lab managers and process chemists often share war stories about how a bad batch of a critical reagent triggered cascading failures, forcing urgent process revalidation. In my experience, building a reliable bridge between bench-scale and larger reactors demands that the core reagents—like 5-Bromoimidazole Pyrazine—hold their properties no matter the batch size or hands. This level of consistency means fewer tweaks, reduced process deviations, and, crucially, gains in both safety and project velocity.

    Sustainability Concerns in Modern Compound Choice

    Sustainability sits at the center of many decisions about which building blocks to bring into the lab. Hazard profiles for waste minimization, solvent compatibility, and decomposability all come up almost every time I discuss chemical sourcing with newer researchers or ESG-minded colleagues. Choosing intermediates such as 5-Bromoimidazole Pyrazine often reflects a growing preference for easily handled and (when possible) less environmentally persistent products. While the compound’s unique chemistry does not resolve all sustainability challenges in synthetic labs, its compatibility with common solvents and manageable hazard profile reflect a step in the right direction.

    Recent papers and patent filings focus on integrating such intermediates into cleaner synthetic pathways, which speaks to broader efforts across R&D groups worldwide. By reducing the need for harsh conditions or toxic co-reagents, this compound lets researchers pursue greener, more future-forward projects without sacrificing robustness or reliability.

    Addressing Cost vs. Value in Research Budgets

    Labs face an unending balancing act between high-value reagents and limited budgets. It’s tempting to stick with a familiar chemical even if it’s not ideal, just to rein in expenses. Yet, product value shows up not just in sticker price but in improved yields, lower rates of failed reactions, and time shaved off troubleshooting uncooperative chemistry. Users who have switched to 5-Bromoimidazole Pyrazine point to fewer reruns, telling stories about improved outcomes that more than justify the upfront investment. Savings made from avoided delays or streamlined purification can deliver bigger returns than the original purchase might suggest.

    Innovation and Real-World Feedback Drive Progress

    As a writer who has watched many “next big thing” compounds cycle through labs only to fizzle out on the ground, I’ve learned to pay attention to the stories coming back from working chemists. Technical write-ups rarely capture the months of trial and error, late-night checks, and quiet satisfaction when an unexpectedly clean NMR reveals progress. Success with 5-Bromoimidazole Pyrazine in exploratory med-chem projects reflects a deeper lesson: chemists value materials that shorten development timelines and reduce ambiguity, letting scientific imagination take the lead.

    Researchers who have incorporated this compound into their synthetic toolbox highlight utility in tandem functionalizations, step-saving cross couplings, and providing reliable access to tricky scaffolds. Many report collaboration successes and patentable innovations made possible through newly unlocked reaction routes. Tangible outcomes—like more robust SAR studies or lower threshold to accessing new chemical space—stand as the measure of real-world utility. These outcomes carry direct influence in both academic success and commercial lead generation.

    Looking Ahead: Meeting Next-Generation Synthetic Challenges

    The future of synthetic chemistry doesn’t rest solely on new reactions or theory; it grows out of sharper tools and more predictable reagents. 5-Bromoimidazole Pyrazine answers a demand for performance combined with the ability to adapt as discovery needs shift. Early accounts from GRAS (Generally Recognized As Safe) investigations and optimized batch reports add support for regular use in regulated environments.

    Every generation of compounds opens up new avenues of inquiry, but widespread adoption relies on a reputation for reliability and value. 5-Bromoimidazole Pyrazine positions itself as a go-to core intermediate for a range of applications—one that lets scientists innovate while operating inside the ever-tighter boundaries of regulatory, economic, and ecological frameworks.

    Practical Solutions for Labs Considering Adoption

    For researchers thinking about bringing 5-Bromoimidazole Pyrazine into their workflows, successful transitions often start with small-scale pilots. Comparing results from parallel reactions against known benchmarks can offer insight into performance and compatibility, especially in multi-step syntheses where reactivity sequence matters. Building partnership with chemical suppliers who offer transparent documentation and batch-level test data pays off in the long run. Having regular contact with technical sales specialists, sourcing managers, and even peer labs using the same reagents closes the information gaps that might otherwise derail implementation.

    As knowledge and user feedback grow, sharing new results—both positive and negative—ensures the compound evolves in line with real scientific advances. In my experience, innovation rarely springs full-grown from a single source; it emerges from open collaboration, purposeful experimentation, and honest assessment of costs, risks, and rewards. In this way, 5-Bromoimidazole Pyrazine offers more than a molecule—it provides an example of how careful sourcing and continuous feedback loop between bench and market drive the scientific process forward.

    Encouraging Responsible Use and Best Practices

    Seasoned lab professionals emphasize that a single compound, no matter how robust, only achieves its full potential through smart use. Detailed record keeping, well-matched solvent systems, and proper waste management all reinforce the benefits of reliable intermediates. Teams who succeed with 5-Bromoimidazole Pyrazine often share protocols, lessons learned, or tips on maximizing recovery and minimizing side product formation. This community-driven approach expands collective know-how, raising the confidence level for those ready to tackle new targets.

    Mentoring junior researchers in the best practices for introducing such intermediates to their workflow multiplies the impact of each breakthrough. Watching a student chemist watch a reaction run cleanly—and seeing their face light up—underscores why products like this matter. Facilitating smoother lab work, cutting down on avoidable errors, and letting the next question drive the next experiment, these moments show the real value in industry advances.

    Final Thoughts on Significance and Opportunity

    Looking over the broader trajectory of chemical research, I see real momentum behind products that blend dependability, creative flexibility, and tangible improvements in workflow. 5-Bromoimidazole Pyrazine stands at the confluence of these trends—not only for its chemical features, but for how it matches the pragmatism of daily research reality. Whether for medicinal chemistry, material science, or even teaching the next generation of scientists, its blend of unique properties and reliable supply represent a move toward more focused, outcome-driven science.

    Trust, proven results, and a willingness to adopt new solutions remain key themes in labs worldwide. Through my own interaction with chemists, I’ve learned nothing replaces hands-on evidence. The steady adoption of 5-Bromoimidazole Pyrazine signals a collective shift: users seek quality, smarter workflow, and shared knowledge—all of which this compound continues to unlock for the scientific community.